Xiaohu Deng
Director Técnico/Científico/I+D en Vividion Therapeutics, Inc. .
Origen de la red de primer grado Xiaohu Deng.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA.
12
| Subsidiary | Miscellaneous Commercial Services | 12 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Xiaohu Deng a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BAYER AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Consultant / Advisor | |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Connecticut | College/University | Undergraduate Degree Graduate Degree | |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member Director/Board Member | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
| Saints Cyril & Methodius University of Skopje | College/University | Doctorate Degree | |
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Chairman | |
| RAYZEBIO, INC. | Biotechnology | Chairman | |
| University of Arizona | College/University | Undergraduate Degree | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chairman | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman | |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
| American Association For Cancer Research Foundation | Director/Board Member | ||
Jewish Federation of Omaha, Inc.
 Jewish Federation of Omaha, Inc. Miscellaneous Commercial ServicesCommercial Services Jewish Federation of Omaha, Inc. offers social, educational and cultural programs through fundraising. It supports communal services in the Omaha area by establishing and accumulating assets for permanent funding resources. The company was founded in 1903 and is headquartered in Omaha, NE. | Miscellaneous Commercial Services | Director/Board Member | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| The Salk Institute for Biological Studies | College/University | Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
| GRITSTONE BIO, INC. | Biotechnology | Director/Board Member | |
| METACRINE, INC. | Biotechnology | Founder | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder | |
| ORGANOVO HOLDINGS, INC. | Biotechnology | Director/Board Member | |
| Moores Cancer Center | Corporate Officer/Principal | ||
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| GERON CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer | |
American Chamber of Commerce in Germany eV
 American Chamber of Commerce in Germany eV Miscellaneous Commercial ServicesCommercial Services American Chamber of Commerce in Germany eV engages in the enhancement of global economic and trade relations. The company was founded on January 29, 1903 and is headquartered in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
BlueRock Therapeutics LP
 BlueRock Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, BlueRock Therapeutics LP is a clinical stage cell therapy company focused on creating cellular medicines to reverse devastating diseases. The company is based in Cambridge, MA. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG as a cornerstone of its newly formed cell & gene therapy platform. The company's culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that they are all part of something bigger than themselves. BlueRock Therapeutics' lead clinical program, Bemdaneprocel (BRT-DA01), is in phase I clinical trials for Parkinson's disease. BlueRock Therapeutics was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG. Seth Ettenberg has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Agenovir Corp.
 Agenovir Corp. Pharmaceuticals: MajorHealth Technology Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Vrije Universiteit Brussel | College/University | Graduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARROWHEAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| Gladstone Foundation (CA) | Director/Board Member | ||
| Rotterdam School of Management | College/University | Masters Business Admin | |
| Ghent University | College/University | Doctorate Degree | |
EcoHealth Alliance, Inc.
 EcoHealth Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services EcoHealth Alliance, Inc. operates a not for profit organization. It protects the health of people, animals, and the environment. Its programs include rift valley fever, predict, health and policy initiatives, monitoring the deadly Nipah virus, emerging disease hotspots, project deep forest, ecohealthy pets, global wildlife trade, and economics of emerging infectious diseases. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor |
Estadísticas
Internacional
| Estados Unidos | 45 |
| Alemania | 3 |
| Bélgica | 3 |
| Macedonia | 2 |
| Países Bajos | 2 |
Sectorial
| Health Technology | 30 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 4 |
| Health Services | 2 |
Operativa
| Director/Board Member | 68 |
| Corporate Officer/Principal | 24 |
| Independent Dir/Board Member | 22 |
| Founder | 14 |
| Chief Executive Officer | 10 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Richard Heyman | 33 |
| Benjamin Cravatt | 19 |
| Jeffrey Hatfield | 18 |
| Christine Siu | 15 |
| Patricia Allen | 14 |
| Marianne de Backer | 14 |
| Christian Rommel | 11 |
| Aleksandra Rizo | 8 |
| Stefan Oelrich | 6 |
| Todd Kinsella | 4 |
| Lisa Percival | 4 |
| Christine Roth | 1 |
- Bolsa de valores
- Insiders
- Xiaohu Deng
- Conexiones Empresas
